Adial Pharmaceuticals Inc... (ADILW)
NASDAQ: ADILW
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Jul 27, 2023, 9:52 PM
Adial Pharmaceuticals WT EXP 073123 Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -13.2M | -13.03M | -12.19M | -10.57M | -7M | -7.96M | -9.73M | -12.73M | -12.73M | -15.7M | -16.9M | -17.5M | -19.42M | -17.06M | -16.08M | -13.45M |
Depreciation & Amortization | 565.00 | 565.00 | 564.00 | -15.14K | 564.00 | 15.97K | 31.09K | 61.63K | 60.5K | 61.34K | 58.36K | 57.35K | 55.11K | 38.86K | 26.72K | 12.89K |
Stock-Based Compensation | 796.83K | 972.29K | 1.05M | 1.59M | 1.82M | 2.2M | 2.49M | 2.85M | 3.37M | 3.52M | 4.16M | 3.9M | 4.24M | 3.73M | 3.22M | 2.77M |
Other Working Capital | 191.06K | 79.56K | -457.3K | -720.34K | -752.4K | -363.48K | -528.29K | -1.04M | -1.48M | -1M | -949.01K | 583.18K | 1.82M | 854.93K | 1.89M | 1.58M |
Other Non-Cash Items | 5.24M | 5.48M | 5.75M | 5.56M | 769.63K | 23.33K | -348.1K | -362K | -522K | 1.3M | 1.65M | 1.66M | 1.81M | 1,245B | 1,245B | 1,245B |
Deferred Income Tax | n/a | 37.18K | -259.25K | -1.25M | -1.25M | -1.28M | -988.05K | -502 | -502 | -94.08K | -94.08K | -94.08K | -94.08K | -1,245B | -1,245B | -1,245B |
Change in Working Capital | 386.14K | 356.24K | -233.86K | -941.91K | -794.21K | -325.47K | -805.56K | -808.22K | -1.37M | -901.14K | -796.78K | 370.73K | 1.46M | 791.82K | 1.93M | 2.02M |
Operating Cash Flow | -6.92M | -6.69M | -6.39M | -6.13M | -6.81M | -7.34M | -9.35M | -10.99M | -11.19M | -11.81M | -11.93M | -11.6M | -11.95M | -12.19M | -10.87M | -8.65M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -64.6B | -64.6B | -64.6B | -64.61B | -64.61K | -64.61K | -30.88K |
Cash Acquisitions | n/a | 350K | 700K | 1.5M | 1.5M | 1.15M | 800K | n/a | n/a | 30.59B | 30.59B | 30.59B | 30.59B | 30.59K | 30.59K | 30.59K |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 350K | 700K | 700K | 700K | 350K | n/a | n/a | n/a | 34.02B | 34.02B | 34.02B | 34.02B | -350K | -350K | -350K |
Investing Cash Flow | n/a | 350K | 700K | 1.5M | 1.5M | 1.15M | 800K | n/a | n/a | 30.59K | 30.59K | -3.14K | -3.43K | -384.02K | -384.02K | -350.29K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | 1.66K | n/a | n/a | n/a | -1.66K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.82M | 3.82M | 3.82M | 3.82M | -1.6K | -1.6K | 58.00 | 1.86K | 1.86K | 456.86K | 456.86K | 455K | 1.89M | 5,607.2B | 5,607.2B | 5,607.2B |
Financial Cash Flow | 7.85M | 11.23M | 7.76M | 7.35M | 4.13M | -8.38M | -8.51M | -8.51M | 1.86K | 10.38M | 15.88M | 18.69M | 13.64M | 5,607.2B | 5,607.2B | 5,607.2B |
Net Cash Flow | 923.44K | 4.89M | 2.07M | 2.71M | -1.17M | -5.44M | -7.94M | -10.38M | -2.06M | -1.43M | 3.95M | 7.05M | 1.66M | -184.95K | -3.41M | 686.28K |
Free Cash Flow | -6.92M | -6.69M | -6.39M | -6.13M | -6.81M | -7.34M | -9.35M | -10.99M | -11.19M | -64.62B | -64.62B | -64.62B | -64.62B | -12.26M | -10.93M | -8.68M |